AlphaYou
Overview
Key stats
Fundamentals Sep 13- Open
- $145.24
- 52-wk high
- $155.38
- High
- $145.99
- 52-wk low
- $106.44
- Low
- $143.50
- Prev close
- $144.81
- Mkt cap
- $178.21B
- Volume
- 4.20M
- Fwd P/E
- 14.8x
- Beta
- 0.35
- Div yield
- 2.22%
- P/S
- 5.8x
- P/B
- 15.2x
- Profit margin
- -10.6%
- Op margin
- +33.7%
- ROE
- -20.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 4.5% above what analysts expected.
Earnings per share
-$7.07 expected
Revenue
No comparable estimate
FY2026 guidance
$30.10B to $30.40B
No comparable estimate
Reports Oct 29, 2026, in 46 days
EPS expected
$1.90 to $2.68
Revenue expected
19 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.77B | $7.92B | $6.96B | $7.80B |
| Cost of what it sold | $1.57B | $1.62B | $1.45B | $1.58B |
| Gross profit | $6.20B | $6.30B | $5.51B | $6.22B |
| What it spent | ||||
| Research and development | $1.35B | $1.58B | $1.37B | $1.76B |
| Sales and admin | $528.0M | $652.0M | $553.0M | $1.92B |
| Other operating costs | $999.0M | $1.08B | $1.00B | $12.93B |
| Total operating expenses | $2.87B | $3.31B | $2.93B | $16.62B |
| What was left | ||||
| Operating profit | $3.33B | $2.99B | $2.69B | -$10.39B |
| Interest on debt | $256.0M | $255.0M | $240.0M | $247.0M |
| Profit before tax | $3.64B | $2.08B | $2.58B | -$10.25B |
| Tax | $589.0M | -$105.0M | $559.0M | $242.0M |
| Net profit | $3.05B | $2.18B | $2.02B | -$10.50B |
| EBITDA | $4.58B | $3.02B | $3.51B | -$10.01B |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Baird Financial Group Inc. Grows Holdings in Gilead Sciences, Inc. $GILD
Leans bullishSep 11If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
BullishSep 10In draft guidance, NICE rebuffs Gilead's twice-a-year PrEP med for national coverage
Leans bearishSep 10Here's Why You Should Add NRIX Stock to Your Portfolio Now
Leans bullishSep 10Tidal Investments LLC Raises Position in Gilead Sciences, Inc. $GILD
Leans bullishSep 10NICE says no to Gilead's lenacapavir for HIV PrEP
Leans bearishSep 10Engineers Gate Manager LP Acquires Shares of 112,886 Gilead Sciences, Inc. $GILD
Leans bullishSep 10Allworth Financial LP Sells 8,687 Shares of Gilead Sciences, Inc. $GILD
Leans bearishSep 10
Macro
30 macro signals shaping GILD right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results